The trademark application ECYMIDE was filed by Bausch Health Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on June 12, 2022, and still open for oppositions.
It was designated 'Basic Application' for International Application 1666924 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).